ACell, Inc. today announced the introduction of two new wound management devices: Cytal Wound Matrix 3-Layer and Cytal Wound Matrix 6-Layer. These devices are intended for the management of partial- and full-thickness wounds including pressure ulcers, venous ulcers, diabetic ulcers, tunneled wounds, traumatic wounds, and surgical wounds.
"Cytal expands ACell's presence in the rapidly expanding wound care market, and complements our portfolio of wound management devices," said Kyle Kerbawy, Chairman of the Board. "Everyone at ACell is focused on offering physicians and their patients effective clinical options, and Cytal addresses an unmet need in chronic and acute wound management."
Cytal wound matrices allow for prolonged persistence of ACell's proprietary Urinary Bladder Matrix (UBM) in the wound, providing for a robust scaffold for cell infiltration and may reduce need for follow up care. The pre-fenestrated design is highly conformable in irregular wound beds and supports effective fluid management. Cytal will be available in three sizes in both 3- and 6-layer configurations.
ACell's wound management portfolio also includes MicroMatrix®, MatriStem® Wound Matrix, MatriStem Multilayer Wound Matrix, and MatriStem Burn Matrix. ACell also manufactures and distributes a line of surgical devices including various MatriStem® Surgical Matrix sheets and MatriStem Pelvic Floor Matrix.